Impact evaluation on the use of the human albumin protocol in consumption rationalization
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Poster
- By: BRAVO, Aurea (Centro Hospitalar Leiria-Pombal, Pharmacy, Leiria, Portugal)
- Co-author(s): Fernandes, A.F. (Centro Hospitalar Leiria-Pombal, Leiria, Portugal)
Rodrigues, A.I. (Centro Hospitalar Leiria-Pombal, Leiria, Portugal)
The Human Albumin (HA) is frequently used without relationship between pharmacological properties and the clinical use. However, it´s an expensive medicine, so is imperative that a strict protocol should be implemented in order to rationalize its use.We initiated in 2003 an awareness program oriented towards the medical teams but only The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.